(LONDON) — Britain has licensed use of a second COVID-19 vaccine, changing into the primary nation to greenlight an easy-to-handle shot that its builders hope will turn out to be the “vaccine for the world.”
The United Kingdom authorities says the Medicines and Healthcare Products Regulatory Agency has made an emergency authorization for the vaccine developed by Oxford University and UK-based drugmaker AstraZeneca.
AstraZeneca chief govt Pascal Soriot stated “today is an important day for millions of people in the U.K. who will get access to this new vaccine. It has been shown to be effective, well-tolerated, simple to administer and is supplied by AstraZeneca at no profit.
He added: “We would like to thank our many colleagues at AstraZeneca, Oxford University, the UK government and the tens of thousands of clinical trial participants.”
The Coronavirus Brief. Everything that you must know concerning the international unfold of COVID-19
Thank you!
For your safety, we have despatched a affirmation e-mail to the tackle you entered. Click the hyperlink to substantiate your subscription and start receiving our newsletters. If you aren’t getting the affirmation inside 10 minutes, please test your spam folder.
